← All organizations

VentiRx Pharmaceuticals Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 1, 2015

Acquired by Celgene → Bristol-Myers Squibb on Feb 14, 2017

Timeline

2000s

Jan 1, 2006
VentiRx Pharmaceuticals Inc.— Founded

2010s

Feb 14, 2017
Celgene— Acquired By
Jan 3, 2019
Bristol-Myers Squibb— Now

Drugs by trial phase (8 distinct, 6 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (6)

NCT02431559CollaboratorPhase 1/Phase 2Nov 1, 2015
NCT02124850Lead sponsorPhase 1Sep 1, 2014
NCT01836029Lead sponsorPhase 2Jul 1, 2013
NCT01666444Lead sponsorPhase 2Oct 1, 2012
NCT01289210Lead sponsorPhase 1/Phase 2Jul 1, 2011
NCT00688415Lead sponsorPhase 1Nov 1, 2008

Details

Founded: Seattle, WA, US Jan 1, 2006
Last known activity: Nov 1, 2015